[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577035":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":41,"collaborators":19,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":16,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":19,"enrollmentInfo":53,"targetDuration":19,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":19,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Jacobs institute","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"SHIELD Study Arm","Active treatment with the Pipeline SHIELD Device",[12],"Device: SHIELD",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","SHIELD","Pipeline SHIELD device under study",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Carlos Pena, PhD, MS","CONTACT","2404810824","cpena@jacobsinstitute.org",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":19},"Jacobs Institute","RECRUITING","Buffalo","New York","14203","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-78.87837,42.88645,{"lat":39,"lon":38},{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Elad Levy","Principal Investigator","100577035","evaluation-of-flow-diverter-technology-device-for-intracranial-aneurysm-shield-100577035",false,"NCT06793059","Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)","Inclusion Criteria:\n\n* Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.\n\nExclusion Criteria:\n\nExclusion Criteria:\n\n* Cannot provide consent or legally authorized representative not available to provide consent Criteria:","ALL","22 Years",{"count":54,"type":55},10,"ESTIMATED","INTERVENTIONAL",[58],"NA","The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms",[61],"Aneurysm","2026-03-06",{"date":64,"type":65},"2026-03-10","ACTUAL",{"date":67,"type":65},"2025-01-01",{"date":69,"type":55},"2027-01-01",{"name":5,"class":6},1]